Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TSLA longs stay together.
Future is now.
World is changing.
TSLA is a strong buy. The future is happening now.
Couldn't have asked for a nicer pullback.
93 serious cases in Israel as of a few days ago.
https://www.timesofisrael.com/serious-covid-19-cases-in-israel-drop-below-100-for-1st-time-since-july/
Probably spread throughout the country.
Good luck finding them and finishing the trial there.
I do know where you can find thousands of seriously I'll people though.
Thinking one last sharp selloff here, then load the boat
No big deal if you've been slowly accumulating.
Very bullish long term here. Way too many potential catalyst to vault this much higher.
Patience. Patience.
Overpriced. Likely to see a bit more weakness in the coming weeks.
Looking to add on further pullbacks. Very bullish long term.
OPTI reporting is a mess
Moving on.
Thoughts on potential Tollovir Covid trial
Starting Tollovir trial for Covid at this point is waste of time and money if Gerald can't get a trial started in Brazil or India. Otherwise, will be very difficult to find enough serious/critical cases in US or Israel to perform a timely trial.
Put the money you've raised into advancing the cancer tests.
120 enrollment for Covid trial will likely never be reached
US and Russia cases dropping sharply. IPIX apparently unwelcome in Brazil and India.
Covid trial will likely never be completed.
Leo should announce resumption of irritable bowel disease test for Brilacidin and announce more toxic financing to fund it. Prediction that outstanding shares will reach 1 billion before July.
Short term price target 15 cents. 10 cents by end of year.
Dr.Oz asks, Where are the fu$!ng Covid treatments?
Are We Falling Behind in Covid-19 Treatments?
Prices of Covid drugs exploding higher as India begs for help
India's COVID-19 Crisis Leads To Black Market Price Explosion
https://www.zerohedge.com/covid-19/indias-covid-19-crisis-leads-black-market-price-explosion
Someone tell India not to worry. FDA has FAST TRACKED Brilacidin. Should have something ready in 2-3 years.
Hang in there...
Dying of COVID while awaiting vaccine-still no treatment available???
April 3, 2021
How about 3-6 more months now filling out paperwork to get a drug reviewed.
https://apnews.com/article/immunizations-coronavirus-pandemic-coronavirus-vaccine-veterans-d43aade61cf70abe1f9de070a8d1280b
The final insult: Some dying of COVID while awaiting vaccine
By JAY REEVES
2 hours ago
After months of hoping to receive a COVID-19 immunization and then weeks of fighting the illness after one never came, Air Force veteran Diane Drewes was down to her last few breaths at a hospice center in Ohio when the phone rang. It was a health care worker, calling to schedule her first appointment for a coronavirus shot.
Drewes’ daughter Laura Brown was stunned by the timing of the call in January but didn’t lash out over the phone or even explain that her 75-year-old mom was at the point of death. There just wasn’t any point, she said.
“But me and my sister were upset that it came too late,” Brown said. “It seemed like the final insult.”
ADVERTISEMENT
More than 247,000 people have died of COVID-19 in the U.S. since vaccines first became available mid-December. Officials had warned that dispensing enough vaccines to reach herd immunity would take months. And with the initial vaccine supply extremely limited and the virus running rampant across the nation over the winter, it was a sad reality that some would contract COVID-19 and die before they could be inoculated.
With surveys showing a large percentage of the U.S. population leery of vaccines, it’s impossible to say exactly how many of the dead would have even wanted an immunization. But Brown said her mother wanted one — desperately. Other families have similar, wrenching stories of loved ones being infected after months of staying safe and then dying before they could get a dose.
Charlotte Crawford, who has spent 40 years working in the microbiology laboratory at Parkland Hospital in Dallas, was fully immunized in January after receiving two doses of the Moderna vaccine because of her work. Yet she then endured the agony of watching her husband and two adult children contract COVID-19 and die before they could get shots.
Henry Royce Crawford, 65, had an appointment for a vaccine when he fell ill, his widow said. Their children, Roycie Crawford, 33, and Natalia Crawford, 38, also wanted the shot but had yet to find one when they got sick and died, Crawford said.
The days since their deaths in late February and early March seem like a jumble to Crawford; she is still trying to sort out what happened as she pleads with anyone who will listen to get a vaccine as soon as possible.
“All I know is I did three funerals in three weeks,” said Crawford, of Forney, Texas.
ADVERTISEMENT
While more than 96 million people in the U.S. have received at least one dose of vaccine, only 53 million are fully vaccinated, or roughly 16% of the nation’s population, according to the Centers for Disease Control and Prevention.
With doses now more widely available, shots are proceeding at a quickened pace. More than a dozen states have opened vaccine eligibility to all adults amid an increase in virus cases.
Only the Johnson & Johnson shot is complete after one dose, so the wait time between the first and second shot of either the Pfizer and Moderna vaccines leaves a period of weeks when a recipient remains vulnerable and subject to infection.
The wait for a second shot proved too long for Richard Rasmussen of Las Vegas, said daughter Julie Rasmussen.
Richard Rasmussen, 73, fervently believed in wearing face masks for protection and had his first dose of the Pfizer vaccine in early January. “He was very excited to get his vaccine,” she said.
Yet Rasmussen tested positive for the virus 10 days later and died Feb. 19 before receiving a second dose, Julie Rasmussen said. His final decline was stunning for its speed, she said.
“And now I am alone,” Rasmussen said in an email interview. “He was my best friend. We texted everyday, all day. I have no siblings. No husband/boyfriend. He was single. I am all alone navigating the legal system and packing his house.”
The same day Rasmussen died, Deidre Love Sullens, of Oklahoma City, was standing in the icy, snow-covered parking lot of a vaccine clinic amid the grief of losing both her mother, Catherine Douglas, 65, and stepfather, Asa Bartlett Douglas, 58, to COVID-19 in a span of 16 days before they could get shots.
“They, and I, looked at the vaccine as the single life-changing factor that would allow us to see one another in person again. It was our goal. We all aimed to get the vaccine so we could gather again, so my mother could play with my daughter again, so we could maybe visit my grandma in the nursing home and not be restricted to window visits,” Sullens said in an interview conducted by email.
On that cold February day, with some doses to spare because foul weather kept others from making appointments, a worker called Sullens in to the clinic to be immunized. Sullens said she was overcome by tears and a “surreal feeling of disbelief” as she entered.
“My mind was thinking, ‘If only my parents could have held out an extra two months ... they’d be here getting the vaccine too. They’d be alive. They’d be here with me,’” she said.
TNXP solid results keep rolling
Congrats Seth. Those with long term view here will be rewarded.$$$$$$$
Covid-No good treatments after 1 year?
Nothing but vaccines that are getting cancelled all over Europe. And those that aren't, how long do they last? A few months/weeks??
Meanwhile, crisis mode in Brazil as Brazilians begging for a treatment that works.
Brazil plunges into deadliest chapter of it's pandemic
March 13, 2021
https://www.theguardian.com/world/2021/mar/13/brazil-covid-coronavirus-deaths-cases-bolsonaro-lula
Covid-No good treatments after 1 year?
Nothing but vaccines that are getting cancelled all over Europe. And those that aren't, how long do they last? A few months/weeks??
Meanwhile, crisis mode in Brazil as Brazilians begging for a treatment that works.
Brazil plunges into deadliest chapter of it's pandemic
March 13, 2021
https://www.theguardian.com/world/2021/mar/13/brazil-covid-coronavirus-deaths-cases-bolsonaro-lula
Italy back to Nov 2020 levels
25,673 cases reported March 11, 2021
https://www.worldometers.info/coronavirus/country/italy
Italy imposes nationwide lockdown AGAIN
Any pharmaceutical companies in Italy aware of any promising therapeutic drugs to fight Covid???? Alphasigma?
Can't make this s#$t up folks..
Italy Imposes National Lockdown As Mutant COVID Strains Spread
March 12, 2021
https://www.zerohedge.com/covid-19/italy-imposes-national-lockdown-mutant-covid-strains-spread
Has Todos' breast cancer test been approved by FDA?
Looks like Covid vaccines are causing a breast cancer scare.
COVID-19 Vaccine Can Cause ‘False Positives’ on Breast Cancer Mammograms
https://www.healthline.com/health-news/covid-19-vaccine-can-cause-false-positives-on-breast-cancer-mammograms
March 2, 2021
HEALTH NEWS
Written by Ann Pietrangelo on March 2, 2021 — Fact checked by Maria Gifford
Experts say breast cancer screenings can be delayed after getting a COVID-19 vaccination, but diagnostic mammograms should not be postponed.
Researchers say swollen lymph nodes caused by COVID-19 vaccination can produce “false positives” in breast cancer mammograms.
Some medical facilities are delaying breast cancer screenings for 4 to 6 weeks after getting the vaccination.
However, experts say a diagnostic exam being done after breast cancer symptoms are discovered should not be postponed.
One potential side effect of the COVID-19 vaccine is swollen lymph nodes.
It’s normal and it’s temporary, but it can lead to unclear mammogram results.
Articles published in the journals Clinical Imaging and Radiology detail several cases of unclear mammogram readings following COVID-19 vaccinations.
In some of those cases, people underwent more imaging tests or biopsies.
The swollen lymph nodes occurred under the arm or near the collarbone on the same side of the body where the vaccine was administered.
“We have observed swollen lymph nodes in the armpit of many women following the COVID-19 vaccine,” said Dr. Emily Sonnenblick, a breast imaging radiologist at the Dubin Breast Center at Mount Sinai Hospital as well as an associate professor of radiology at the Icahn School of Medicine at Mount Sinai in New York.
“Lymph nodes are part of the body’s immune system. They swell as a normal response to a foreign substance, such as vaccine or infection,” she added.
Swollen lymph nodes and mammography
Radiologists look for suspicious changes in the breast and armpit.
Enlarged lymph nodes can be a sign of cancer.
“But an isolated swollen lymph node in the absence of known breast cancer is a rare first sign of cancer,” Sonnenblick told Healthline.
Dr. Clayton Taylor is a breast radiologist with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Taylor told Healthline that it’s too soon to know how common swollen lymph nodes are after a COVID-19 vaccination. There’s also uncertainty how they might be seen on a screening mammogram and cause a false-positive result.
“However, from our experience since January of this year, the risk of a false-positive screening mammogram from a swollen lymph node associated with COVID-19 vaccination seems very small, as long as we collect information from our patients regarding COVID-19 vaccination status at the time of their appointment,” Taylor said.
“If a swollen lymph node from COVID-19 vaccination was identified on a screening mammogram and found to require further evaluation, we would ask the patient to return for a focused ultrasound evaluation of this area,” he added.
Strong buy TSLA.
Shakin' and bakin'.
Know what you own.
World going to electric cars
Biden Admin will lead the U.S.
TSLA strong buy!
Market makers shaking out longs from sub 5 cents.
If you held from under 4 to nearly 40 and you didn't take the 10x trade? Why?
Cause OPTI is going to dollar land!!!
Tough to be patient here.
Remember why you entered this trade and you will be fine.
Didn't think I'd have a chance at INO sub $10
Thanks to those short-term traders dumping.
Hang in there long-time longs.
NNVC is in fine shape
Patience will be rewarded.
Still thinking triple here, maybe not as soon as some would like.
Know what you own. And hopefully you are able to add on weakness like this.
You know big money is adding...
TNXP in accumulate zone
Anything under a dollar is a steal.
Buy, hold, and be patient.
Know what you own and you will be rewarded.
Lot of shaking going on
Hang in there SRNE folks. Patience will be rewarded.
Diversify your holdings and hopefully you kept a little cash...now is the time to put it to use.
Covid cases rising in Europe/Middle East
And still very high in Brazil.
See country by country stats here:
https://www.worldometers.info/coronavirus/
Ignore all the BS false narrative from the media that covid is winding down and things are getting back to normal.
High probability of another U.S. surge.
Testing companies in a good position to help. Too bad Todos doesn't have more international exposure.
Gastrointestinal symptoms and COVID-19
Just another reason why boats are being loaded here by long time IPIX longs.
See article below.
https://www.medicalnewstoday.com/articles/gastrointestinal-symptoms-in-covid-19-what-do-we-know-so-far
Written by Jennifer Huizen on February 12, 2021 — Fact checked by Alexandra Sanfins, Ph.D.
In this Special Feature, we round up the existing evidence on the gastrointestinal symptoms in COVID-19.
Respiratory symptoms are the most common symptom of COVID-19.
But according to a recent review, 53% of people hospitalized with COVID-19 experience at least one gastrointestinal (GI) symptom at any time during their illness.
And there’s increasing evidence that encountering GI symptoms with COVID-19, or developing COVID-19 alongside underlying GI conditions, may increase the risk of disease severity and negative complications.
In this Special Feature, Medical News Today review what we know so far about the relationship, prevalence, and impact of GI symptoms on COVID-19 infections.
Article highlights:
GI symptoms associated with COVID-19
Respiratory symptoms, such as coughing or trouble breathing, are the most common symptoms of COVID-19.
But early reports out of China made it clear that COVID-19 can also trigger GI system symptoms. The GI system includes:
the mouth, esophagus, stomach, small and large intestines, the anus.
The first person with confirmed COVID-19 in the United States also experienced 2 days of nausea and vomiting before developing diarrhea. And one of the earliest American studies found that around 32% of patients with the disease experienced diarrhea, nausea, or loss of appetite.
The research is ever-evolving. But according to a review published this month analyzing 125 articles and a total of 25,252 patients, the most common GI symptoms associated with COVID-19 include:
lack of appetite (19.9%)
lack of smell or taste (15.4%)
diarrhea (13.2%)
nausea (10.3%)
vomiting up blood or GI bleeding (9.1%)
Another review published in late January found much broader ranges of symptom prevalence rates, such as:
diarrhea (9–34%)
nausea, vomiting, or both (7–16%)
abdominal pain (3–11%)
Less commonly, COVID-19 may also cause:
belching
acid reflux
indigestion
colitis, or intestinal inflammation
GI bleeding
The disease may also destroy bowel tissues and reduce intestinal movement.
Right now, it seems most people who experience GI symptoms with COVID-19 develop them alongside respiratory symptoms.
However, a review from late 2020 found around 20% of people with COVID-19 infections only experience GI symptoms. And sometimes, these symptoms develop before respiratory symptoms or fever develop.
Early studies suggest GI symptoms tend to occur during the early stages of the infection. But more research is needed to confirm when GI symptoms develop in COVID-19 cases if there is a specific time frame.
How COVID-19 causes GI symptoms
Researchers are still learning more about how infection with SARS-CoV-2 affects different parts of the body.
There is evidence that SARS-CoV-2 can infect cells in the respiratory and GI tract, as well as cells in other locations in the body.
Most studies show the SARS-CoV-2 virus enters intestinal cells, or enterocytes, and respiratory cells using the angiotensin-converting enzyme 2 (ACE-2) protein as a receptor. The ACE-2 receptor is embedded in cellular membranes. It helps regulate blood pressure by controlling levels of the protein angiotensin, which encourages blood vessels to constrict and raise blood pressure.
The virus enters intestinal cells after its characteristic spike proteins bind to ACE-2. Once inside the cell, the virus uses the cells’ own machinery to produce copies of viral proteins and ribonucleic acid (RNA). RNA is the genetic material of retroviruses, such as SARS-CoV-2, much like human DNA.
When SARS-CoV-2 particles leave an infected cell, it triggers the release of cytokines, small proteins that play a role in inflammation. This process may cause GI symptoms.
GI symptoms can also occur as viruses destroy or damage GI tissues, especially pain, nausea, and diarrhea. Some research shows that COVID-19 may also change the gut microbiota, the community of microbes that normally inhabit the intestines or stomach.
Once in the GI tract, the virus can also travel through the portal vein, the vein that drains blood from the digestive tract. This can allow viruses to impact the vagus nerve, causing a nauseous sensation.
Nausea and diarrhea are also common symptoms of medications that healthcare professionals often use to manage COVID-19, such as antivirals and antibiotics.
There is increasing evidence that SARS-CoV-2 could pass on to others via fecal-oral transmission. This means people could acquire an infection by accidentally consuming or inhaling droplets of infected feces.
In fact, fecal samples from the first person with confirmed COVID-19 in the U.S. contained virus particles. Other coronaviruses can also cause viral shedding, referring to the release of viral particles in feces.
Some research even suggests people may shed viral particles in their feces after the virus is undetectable in the upper respiratory system, such as the lungs, nose, or throat.
If true, this could change how someone can spread the virus to others and for how long. But researchers have yet to determine whether the proteins and particles shed in feces are infectious, or capable of actually causing disease.
GI symptoms and disease outcomes
People who experience GI symptoms with COVID-may be more likely to develop negative health complications or risks.
A study from November 2020 found experiencing these symptoms heightened the risk of developing acute respiratory distress syndrome, as have several studies since then.
The study also found that experiencing GI symptoms increased the risk of undergoing procedures with major health risks, such as noninvasive mechanical ventilation and tracheal intubation.
And a report from October 2020 found children with COVID-19 who develop GI symptoms were more likely to experience severe, critical infections and cardiac impairments.
Another study from late January 2021 concluded that experiencing these symptoms also seems to increase the likelihood of developing severe disease and dying in adults. An even more current review found people with COVID-19 and GI symptoms on admission to the hospital were also more likely to develop acute heart and kidney damage or die from the disease.
Dozens of studies have also found that people with preexisting GI conditions are more likely to experience serious disease and negative complications.
Research published this month found people with GI conditions, such as Barrett’s esophagus, seem to be at an increased risk of developing severe COVID-19 symptoms and disease.
Some researchers speculate this connection probably exists because GI diseases can cause intestinal metaplasia, which replaces the stomach lining with cells similar to intestinal lining cells.
Many GI conditions may also make it easier to develop GI infections because they damage or weaken the intestinal or stomach lining. Some of these conditions, such as irritable bowel syndrome, also cause the over-expression of ACE-2, giving viruses more opportunities to enter cells.
Medications used to treat GI diseases or symptoms can also reduce stomach acid levels, making it easier to contract the virus from foods or other ingested substances. Normally, the stomach’s high acidity levels are strong enough to deactivate viral particles.
Less speculation exists as to why experiencing GI symptoms with COVID-19 seems to increase the risk of severe disease and poor outcomes in the absence of underlying conditions.
People with viral infections in their respiratory and GI tract are exposed to increased viral load when compared with people with infections in only the respiratory tract.
There are also around 100 times more ACE-2 receptors in the GI tract than respiratory organs, so it may be able to house more viruses when it acquires an infection.
People with symptoms impacting multiple organs also tend to experience more severe disease and poorer outcomes.
Early evidence seems consistent. But a wider scale, long-term studies need to determine the true relationship between GI symptoms, GI conditions, and COVID-19.
For example, some research indicates people who develop GI symptoms with COVID-19 may actually experience milder disease.
Remaining questions
Knowing how often, when, and why COVID-19 causes GI symptoms could have significant benefits.
If these symptoms are as common as research shows, doctors and nurses could start testing people with these indicators, namely loss of smell and taste, fever, anorexia, and diarrhea, as highly specific for COVID-19 infection — even in people without respiratory symptoms. This could help identify potentially millions of COVID-19 cases earlier, including otherwise asymptomatic cases.
Tracking GI symptoms in a population may also help identify disease outbreaks before they occur.
A study comparing rates of internet searches for these symptoms commonly associated with COVID-19 in 15 states found that, in some states, surges in searches occurred 3–4 weeks before surges in case levels.
Researchers also need to know if preexisting GI diseases increase the risk of developing severe disease, negative complications, and dying. They will also have to figure out whether GI conditions make someone more susceptible, or prone, to developing COVID-19. This could teach healthcare professionals how to handle potential, active, or resolved cases of COVID-19 in people with GI diseases better.
It will also be important to learn whether COVID-19 can spread through feces and how long someone remains contagious.
In a review from early February, feces samples from 26.7% of individuals with confirmed COVID-19 contained viral RNA and shed infective particles for roughly 19 days.
If the disease can spread through feces, this could change current hygiene and self-isolation recommendations.
The Centers for Disease Control and Prevention (CDC) currently also only recommend people self-isolate for 10–20 days after symptom onset. If someone’s feces remain capable of spreading infection for longer, public health bodies may have to consider reviewing their guidelines.
If feces containing the new coronavirus can spread the infection, it will also be important to monitor and potentially treat wastewater to reduce transmission. The CDC already have the tools to help states create their own surveillance sampling strategies.
Researchers also need to learn more about the long-term GI impacts associated with COVID-19.
Some preliminary studies show certain symptoms may persist for weeks to months after recovering from the disease. A recent review found approximately 16% of people may still experience nausea and vomiting after recovering, while 12% may continue to experience digestive disorders.
It will take time to truly uncover when and why COVID-19 triggers GI symptoms, and how they impact disease severity and outcomes. And it will likely take much longer to figure out if, and how often, symptoms become long-term.
But as daunting as it sounds, this knowledge could bring about substantial improvements in how we diagnose, treat, monitor, and track COVID-19.
NNVC is not in penny land
Institutional interest will be high
NNVC could triple today?
Outstanding shares very low
Well managed company.
Thank you for the...
Pullback and great news
$1-$2 by summer
Should have easily driven the price down to 2.5-3.0 cents.
Someone is heavily accumulating shares.
Leo's memoirs of 2020 will be fascinating
Absolutely fascinating reading.
To be read by the fireplace with a little vodka.
Russian claims on Covid antidote
https://www.dailystar.co.uk/news/world-news/russia-claims-its-developed-first-23243109
FDA still busy analyzing hand sanitizer companies. Priorities...
Game on.
This is getting very interesting.
United-first U.S. airline to offer in-airport coronavirus testing
https://www.cbsnews.com/news/covid-test-united-airlines-travel-ready-center-airport
February 15, 2021--United Airlines is now the first U.S. airline to offer passengers access to in-airport coronavirus testing. The rollout is a streamlined way for passengers to book a ticket, schedule a test and upload the results on the company's app, in what travel experts say could be the "new normal" of travel.
Almost a year into the pandemic, people across the globe are still confused over how to follow a patchwork of COVID-19 travel guidelines and protocols.
"I was thinking the entire time as I was coming here, waiting for my COVID test to come in," traveler Noah Johnston told CBS News' Errol Barnett. "It adds another layer onto travel that under normal circumstances you don't have to be worried about."
United Airlines' "Travel Ready Center" is aiming to fix the issue.
The digital platform allows passengers to do everything from check COVID-19 requirements to schedule a test at the terminal. Whereas before, a traveler may be stuck jumping from page to page on various government websites, United's new app ensures relevant information is attached directly to their ticket based on where they are going.
"Based on the ticket that you purchased, tailored to you so that you will know everything that you need, particularly as all the COVID kind of landscape is changing," United Airlines President of Digital Products Michelle Brown said.
Coronavirus Crisis
Inside United Airlines' in-airport coronavirus testing center
Study: Pfizer vaccine 94% effective at preventing symptomatic infections
Eager for a stimulus check? Early tax filing might help
Pharmacies offering COVID-19 vaccines: What you need to know
MORE
CBS News had a firsthand look at the testing process at Newark Liberty International Airport's XpresCheck — owned by Xpres Spa Group, a company that previously mainly focused on spas inside airports — where United's new pop-up site opens Monday.
XpresCheck CEO Doug Satzman said his company was uniquely positioned to offer COVID19 testing inside the terminal, having switched focus from manicures and massages to medical testing.
"Our spa business closed down at the end of March," Satzman said. "So here we have three zones — We have a check-in, we have testing rooms, and then we have a full service lab."
He noted the update will likely not be going away anytime soon.
"Like 9/11 changed air security forever, we're still taking our shoes off," he said. "COVID is going to change safety protocol in airports for a long time as well."
Once tested, passengers upload results to their booking profile.
"The airlines are investing in providing testing because they know it's good business," travel industry analyst and Atmosphere Research Group President Henry Harteveldt said, adding that the move came from necessity.
He continued, "Some countries or destinations want you to have a PCR test. Others will take an antigen test. So it's really confusing."
Dr. William Schaffner, a professor of infectious diseases at Vanderbilt University School of Medicine, noted that while the process is more straightforward and could be the future of flying, a negative rapid test result does not guarantee safety.
"It's not perfect, but it is another layer that could be introduced to help reduce the risk," he explained
Since its app launch three weeks ago, United says they have already seen hundreds of thousands of customers upload their COVID-19 test results before boarding their flights.
In addition to rapid tests, the "Travel Ready Center" also offers PCR or antigen tests. The centers are so far available in Newark, San Francisco and LAX airports, with plans to expand.
First published on February 15, 2021 / 11:59 AM
© 2021 CBS Interactive Inc. All Rights Reserved.
Peer reviewed paper and FDA fastrack speak volumes
Don't think many investors are here to flip for a few pennies. Sure new cases are falling, but worldwide more than 25 million cases and in the U.S. nearly 10 million cases that have not recovered.
https://www.worldometers.info/coronavirus
Not sure why all the secrecy here
Other companies don't seem to have this issue. If there has been a delay, I think the market can handle it.
IPIX on ClinicalTrials.gov
Nothing reported yet regarding an IPIX Covid trial yet.
Maybe someone should notify the CEO here...?
When a trial starts, you'll see it reported here. And yes, other companies do have Covid trials underway. And yes, those trials do appear on Clinical trials.gov.
https://clinicaltrials.gov/ct2/results?cond=&term=%22Innovation+Pharmaceuticals%22&cntry=&state=&city=&dist=&Search=Search&recrs=a&recrs=b&recrs=d&recrs=e&recrs=f&recrs=g&recrs=h&recrs=i&recrs=m
Tonix in ClinicalTrials.gov
Nothing new. Just FYI.
https://clinicaltrials.gov/ct2/results?cond=&term=%22Tonix%22&cntry=&state=&city=&dist=&Search=Search&recrs=a&recrs=b&recrs=d&recrs=e&recrs=f&recrs=g&recrs=h&recrs=i&recrs=m
Go TNXP!!
Sorrento on ClinicalTrials.gov
Nothing new. Just FYI.
https://clinicaltrials.gov/ct2/results?cond=&term=%22Sorrento%22&cntry=&state=&city=&dist=&Search=Search&recrs=a&recrs=b&recrs=d&recrs=e&recrs=f&recrs=g&recrs=h&recrs=i&recrs=m
Go SRNE!!